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ABSTRACT: Rubella infection is generally mild in children. However, infection during pregnancy can leads to fetal 
death or congenital defects known as Congenital Rubella Syndrome. The seroprevalence of IgG to rubella virus was 
determined using Enzyme Linked Immunosorbent Assay among 400 pregnant women between the ages of 15-45 
years attending ante-natal clinics in Kaduna metropolis. Of the 400 samples tested, consisting 20 in their first 
trimester, 260 in second and 120 in third trimester, 386 (96.5%) were IgG seropositive. Seroprevalence of 95.2% - 
100% was obtained across the age groups. In relation to stages of pregnancy 19 (95.0%), 251 (96.5%) and 116 
(96.7%) were seropositive in 1st, 2nd and 3rd trimesters respectively. The seroprevalence obtained in this study 
indicates that majority of the pregnant women had protective antibody due to previous exposure to the virus. 
However, 3.5% of the pregnant women were susceptible. Therefore, there is a need for government to incorporate 
rubella vaccine to be part of national immunization programme and screening of women of childbearing age so as to 
reduce subsequent burden of congenital rubella. 
Keywords: Rubella, Seroprevalence, Pregnancy, Antibody, ELISA 
INTRODUCTION 
Rubella, commonly known as German measles is an 
infection caused by Rubella virus. Rubella virus is the 
only member of the genus Rubivirus, which belongs to 
the family Togaviridae (Brooks et al., 2004). It is 
transmitted through respiratory droplet or transplacental 
infection of foetus during pregnancy (Stevens, 2010). 
Humans are the only known host of the virus, which 
occurs throughout the world (Hunt, 2008). The 
incubation period is 14days with a range of 12-23days. 
The symptoms ( although often mild in children) include 
low-grade fever, malaise, lymphadenopathy, upper 
respiratory symptoms and maculopapular rash. Infected 
adult women develop athralgia and arthritis (CDC, 
2012). 
Maternal rubella infection during the first trimester of 
pregnancy may have severe consequences, including 
miscarriage, stillbirth or congenital rubella syndrome 
(CDC, 2012). Infants born with congenital rubella 
syndrome (CRS) may present a number of 
abnormalities, including the most common, which are 
deafness, eye defects (cataracts and glaucoma), 
cardiac abnormalities, mental retardation and motor 
disabilities (Stevens, 2010). 
Studies carried out in Nigeria, revealed seroprevalence 
of rubella IgG in pregnant women to be 54.1% in 
Maiduguri (Bukbuk et al., 2002), 68.5% in Ibadan 
(Bamgboyeet al., 2004), 97.9% in  Zaria (Mohammed et 
al., 2010) 53.0% in Benin (Onakewhoret al.,2011) and 
93.1% in Zaria (Olajide et al., 2012).  
The World Health Organization, (2012) reported that 
Rubella cases have increased in Nigeria from 450 in 
2010 to 3,691 in 2011. Humans are the only known 
reservoir of the virus (CDC, 2012) Pregnant women 
continue to harbor the virus and risk of CRS    
The aim of this study was to determine the 
seroprevalence of rubella virus IgG among pregnant 
women attending ante-natal clinics in Kaduna 
metropolis, Nigeria  
MATERIALS AND METHODS 
Study Design 
A cross-sectional study was carried out among 
pregnant women attending Yusuf Dantsoho, Barau 
Dikko and Gwamna Awan ante-natal clinics in Kaduna 
metropolis. Ethical approval was obtained from Kaduna 
State Ministry of Health. A structured questionnaire was 
administered to consenting pregnant women to obtain 
information on risk and socio-demographic factors prior 
to sample collection.  
Mangga et al.: Seroprevalence of Rubella Specific IgG Antibody among Pregnant Women Attending Ante-Natal Clinics… 
64 
Blood Sample Collection and Processing 
Three milliliters (3ml) of blood were collected from 400 
consenting pregnant women by venopuncture between 
December 2011 to March 2012. The blood was allowed 
to clot and centrifuged at 3000 rpm for 5 minutes. The 
sera was carefully aspirated into  plain bottles and 
stored at -20oC until analyzed (Bamgboyeet al., 2004). 
 
Analysis of blood Samples 
Laboratory analysis was carried out in the Department 
of Microbiology Ahmadu Bello University, Zaria. The 
samples were analyzed for rubella IgG antibody using a 
qualitative rubella IgG ELISA kits (Genesis Diagnotics 
Ltd, Cambridgeshire, UK). Samples with absorbance 
values ≥ absorbance of the standard are considered 
positive while absorbance < absorbance of the 
standard are considered negative. The obsorbance was 
read at 450nm (Bamgboyeet al., 2004) 
 
Data Analysis 
The data obtained from questionnaires and laboratory 
analysis were analyzed using Statistical Package for 
Social Sciences version 16. Pearson Chi-square was 
calculated at 95% confidence interval and p-value < 
0.05 was considered significant to determine the 
association between the presence of the antibodies to 
the virus and other parameters (Araoye, 2004). 
 
RESULTS 
Out of the 400 sample tested, 386 (96.5 %) were 
seropositive while 14 (3.5 %) were seronegative for IgG 
to rubella virus. There was significant association 
between the study sites and viral seroprevalence (χ2 = 
7.307, df = 2, p = 0.02)  (Table 1), the highest 
seroprevalence of  99.3 % (133/134) was recorded 
among pregnant women who were attending Yusuf 
Dantsoho Memorial Hospital while those attending 
Gwamna Awan General had the lowest prevalence of 
93.2 % (124/133).There were similarly higher antibody 
seroprevalences across all the age groups of 15-
45years, which range between 95.2% to 100%. This 
was however, not statistically significant (χ2=0.588; 
df=5; p=0.989) (Table 2). The seroprevalence in 
relation to gestational age of pregnancy is shown in 
Table 3. A total of 19 (95.0%), 251 (96.5%) and 116 
(96.7%) of the women were seropositive during 1st, 2nd 
and 3rd trimesters of pregnancy respectively.  
 
DISCUSSION 
The seriousness of Rubella is on its teratogenic effect 
in women particularly when infected during the first 
eight weeks of pregnancy (De Santis et al., 2006).The 
seroprevalence obtained in this study is similar to the 
previous reports of 97.7%, 93.1% and 89.4% by 
Muhammad et al., (2010), Olajideet al. (2012), in Zaria 
and Adewumi et al. (2013) in Ibadan Nigeria while 
88.6% and 92.9% were reported by Fokunanget al 
(2010) in Younde, Cameroun and Kumbich et al. (2012) 
in Eldoret, Kenya respectively. 
 
Table 1: Seroprevalence of Rubella IgG Antibodies 
among Pregnant Women Attending Ante-natal 









134 133 ( 99.3)  
BarauDikko 133 129 (96.9)  
GwamnaAwan 133 124 (93.2) 0.02 
Total 400 386 (96.5)  
 
Table 2: Age-related Seroprevalence of Rubella IgG 
Antibodies Among Pregnant Women Attending 










15-20 84 82   (97.6)  
21-25 136 131 (96.3)  
26-30 105 101 (96.2)  
31-35 51 49   (96.1) 0.989 
36-40 21 20   (95.2)  
41-45 3 3     (100)  
Total  400 386 (96.5)  
 
Table 3: Gestational Age-related Seroprevalence of 
Rubella IgG Antibodies among Pregnant 
Women Attending Ante-natal Clinics in 







First  20 19  (95.0)  
Second  260 251 (96.5)  
Third  120 116 (96.7) 0.930 
Total  400 386 (96.5)  
 
The IgG antibody presence may possibly be due to 
previous exposure since none of the pregnant women 
was previously vaccinated against this virus (from our 
questionnaire survey). Overcrowding, asymptomatic 
nature of rubella and mode of transmission of the 
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infection might be the attributable factors to the 
seroprevalence obtained in this study. Close contact is 
known to enhance transmission of infection that can be 
acquired through air. More than 50% of rubella infection 
is subclinical. Asymptomatic carriers transmits the 
infection to susceptible individuals through 
nasopharyngeal secretions and infants born with CRS 
excretes the virus through body secretion as well (CDC, 
2012). This study was carried out in the three major 
ante-natal clinics located in the densely populated 
areas of Kaduna metropolis. Similarly, previous studies 
by Bamgboye et al. (2004) and Tahita et al. (2013) 
showed higher seroprevalence of rubella antibody 
among pregnant women in the urban cities. Also, 
Fokunang et al. (2010) observed overcrowding and the 
ease with which the virus spreads among unvaccinated 
population attributes to high seroprevalences.  
 
The seroprevalence was similar across the age groups. 
All the pregnant women were equally exposed in this 
study. Prior to wide-spread use of rubella vaccines, this 
was mainly disease of children. However, today it 
occurs most often in young adults (Meissner et al., 
2006). Previous studies  in Maiduguri and Ibadan  
(Bukbuk et al., 2002; Adewumi et al., 2013) showed 
higher prevalence of 74.4% in 30 to 40years; 100% in 
40years respectively. 
 
 In this study majority of the pregnant women started 
seeking for ante-natal care in Kaduna metropolis late,  
during their second (65.0%) and third (30%) trimesters. 
The maternal protective antibody (IgG) will prevent the 
virus from crossing the placenta thus causing minimal 
congenital effect to the foetus (Singh et al., 2009). 
However, the small percentage (3.5%) of  pregnant 
women who were found seronegative especially in their 
first and second trimesters have a high risk of 
transmitting the infection to the foetus in contact with 
the virus and this could  lead to CRS (Kim et al., 2006). 
 
CONCLUSION AND RECOMMENDATION 
In this study majority of the pregnant women were 
previously exposed to rubella virus hence developed 
protective antibody. This study has established that 
there are susceptible pregnant women to rubella virus 
infection and stand the chance of transmitting the virus 
to their unborn child. There is need for the government 
to incorporate rubella vaccines to be part of National 
Immunization Programme and screening of women of 
childbearing age so as to reduce subsequent burden of 
congenital rubella. 
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